tirzepatide vs semaglutide for weight loss Retatrutide vs Semaglutide vs. Tirzepatide for weight

Serious side effects are rare but may include: Skin issues (rash, blisters, peeling) Vision problems (blurred vision, loss of vision, double vision, eye pain, redness) Seizures Feeling cold, chills, or a low body temperature Cognitive issues (difficulty concentrating, speech problems, confusion, memory problems) Coma (loss of consciousness) Coordination problems Heart-related symptoms (pounding or irregular heartbeat, chest pain, shortness of breath) Altered mental state (inability to respond to surroundings or mood changes) Tiredness Gastrointestinal problems (diarrhea, vomiting, loss of appetite) Kidney issues (intense back or side pain, abnormal urine) Frequent urination, pain while urinating Signs of infection (fever) Bleeding or bruising problems Osteoporosis In general, higher doses of topiramate are associated with an increased risk of adverse reactions

A Comprehensive Review on Weight Gain Following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity

Key Takeaways In 2024, the market for GLP-1 receptor agonist generated a revenue of US$ 53.5 billion , with a CAGR of 17.5% , and is expected to reach US$ 268.4 billion by the year 2033

Can I split a higher-dose pen to make it last longer

Data Sources The PubMed and EMBASE databases were searched up to November, 1st 2023

Focus on GLP-1 drugs & eye problems Im following a number of problems associated with GLP-1 drugs for overweight, obesity or Type 2 diabetes